- Home
- SES vs MXCT Comparison
SES vs MXCT Comparison
Compare SES & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SES
- MXCT
- Stock Information
- Founded
- SES 2012
- MXCT 1999
- Country
- SES United States
- MXCT United States
- Employees
- SES N/A
- MXCT N/A
- Industry
- SES Auto Parts:O.E.M.
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SES Consumer Discretionary
- MXCT Health Care
- Exchange
- SES Nasdaq
- MXCT Nasdaq
- Market Cap
- SES 355.0M
- MXCT 398.3M
- IPO Year
- SES N/A
- MXCT 2021
- Fundamental
- Price
- SES $0.30
- MXCT $3.45
- Analyst Decision
- SES Sell
- MXCT Strong Buy
- Analyst Count
- SES 2
- MXCT 3
- Target Price
- SES $1.25
- MXCT $8.67
- AVG Volume (30 Days)
- SES 4.1M
- MXCT 588.5K
- Earning Date
- SES 10-31-2024
- MXCT 11-06-2024
- Dividend Yield
- SES N/A
- MXCT N/A
- EPS Growth
- SES N/A
- MXCT N/A
- EPS
- SES N/A
- MXCT N/A
- Revenue
- SES N/A
- MXCT $45,599,000.00
- Revenue This Year
- SES N/A
- MXCT N/A
- Revenue Next Year
- SES N/A
- MXCT $21.59
- P/E Ratio
- SES N/A
- MXCT N/A
- Revenue Growth
- SES N/A
- MXCT 19.85
- 52 Week Low
- SES $0.20
- MXCT $3.22
- 52 Week High
- SES $2.44
- MXCT $5.55
- Technical
- Relative Strength Index (RSI)
- SES 32.20
- MXCT 45.15
- Support Level
- SES $0.20
- MXCT $3.17
- Resistance Level
- SES $0.39
- MXCT $3.61
- Average True Range (ATR)
- SES 0.05
- MXCT 0.25
- MACD
- SES 0.00
- MXCT -0.01
- Stochastic Oscillator
- SES 44.00
- MXCT 30.96
About SES SES AI Corporation
SES AI Corp is a pre-commercialization stage company engaged in the development and initial production of high-performance Lithium-Metal (Li-Metal) rechargeable battery technologies for electric vehicles (EVs), urban air mobility (UAM), which encompasses electric vehicle take-off and landing (eVTOL), and other applications. The company is an integrated Li-Metal battery manufacturer with capabilities in material, cell, module, AI-powered safety algorithms, and recycling.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.